BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19.10.2016

Emerging Issues and Cross-Cutting Scientific Advances; Establishment of a Public Docket

The Food and Drug Administration (FDA) is establishing a public docket to receive input on emerging issues and cross-cutting scientific advances that may impact FDA preparedness and inter-Agency activities. Interested parties are invited to submit comments regarding emerging technologies and cross-cutting scientific advances of importance to FDA. The focus is on areas that may impact FDA in 5 or more years.

Source: Federal Register — Food and Drug AdministrationOpen original release →